Literature DB >> 25156245

A novel homozygous MCOLN1 double mutant allele leading to TRP channel domain ablation underlies Mucolipidosis IV in an Italian Child.

Marisol Mirabelli-Badenier1, Mariasavina Severino, Barbara Tappino, Domenico Tortora, Francesca Camia, Clelia Zanaboni, Fabia Brera, Enrico Priolo, Andrea Rossi, Roberta Biancheri, Maja Di Rocco, Mirella Filocamo.   

Abstract

Mucolipidosis type IV (MLIV) is a very rare disorder of late endosome/lysosome transport, characterized by neurodevelopmental abnormalities and progressive visual impairment owing to corneal clouding and retinal dystrophy. Greater than 70 % of MLIV patients are of Ashkenazi Jewish ancestry. Here we report a novel MCOLN1double mutant allele [c.395_397delCTG;c.468_474dupTTGGACC] which introduces a premature stop codon [p.Ala132del; p.Asn159LeufsX27] leading to almost complete abrogation of the region coding mucolipin-1, a member of the transient receptor potential (TRP) cation channel family. The genomic lesion was identified in homozygous state, in a non-Jewish Italian MLIV patient, who also presented abnormal serum gastrin levels. Conventional and advanced MRI sequences, including diffusion tensor imaging and tractography, were used for the assessment of white matter involvement in the patient.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25156245     DOI: 10.1007/s11011-014-9612-6

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  25 in total

1.  Somatotopic organization of motor pathways in the internal capsule: a probabilistic diffusion tractography study.

Authors:  C Pan; K K Peck; R J Young; A I Holodny
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-29       Impact factor: 3.825

Review 2.  Inborn errors of metabolism: a cause of abnormal brain development.

Authors:  A Nissenkorn; M Michelson; B Ben-Zeev; T Lerman-Sagie
Journal:  Neurology       Date:  2001-05-22       Impact factor: 9.910

3.  Loss of TRPML1 promotes production of reactive oxygen species: is oxidative damage a factor in mucolipidosis type IV?

Authors:  Jessica Coblentz; Claudette St Croix; Kirill Kiselyov
Journal:  Biochem J       Date:  2014-01-15       Impact factor: 3.857

4.  Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV.

Authors:  Bhuvarahamurthy Venugopal; Marsha F Browning; Cyntia Curcio-Morelli; Andrea Varro; Norman Michaud; Nanda Nanthakumar; Steven U Walkley; James Pickel; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2007-10-02       Impact factor: 11.025

5.  The neurogenetics of mucolipidosis type IV.

Authors:  G Altarescu; M Sun; D F Moore; J A Smith; E A Wiggs; B I Solomon; N J Patronas; K P Frei; S Gupta; C R Kaneski; O W Quarrell; S A Slaugenhaupt; E Goldin; R Schiffmann
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

6.  Neuropathology of the Mcoln1(-/-) knockout mouse model of mucolipidosis type IV.

Authors:  Matthew C Micsenyi; Kostantin Dobrenis; Gloria Stephney; James Pickel; Marie T Vanier; Susan A Slaugenhaupt; Steven U Walkley
Journal:  J Neuropathol Exp Neurol       Date:  2009-02       Impact factor: 3.685

7.  Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV.

Authors:  M T Bassi; M Manzoni; E Monti; M T Pizzo; A Ballabio; G Borsani
Journal:  Am J Hum Genet       Date:  2000-09-29       Impact factor: 11.025

8.  Different molecular mechanisms leading to white matter hypomyelination in infantile onset lysosomal disorders.

Authors:  M Di Rocco; A Rossi; G Parenti; A E M Allegri; M Filocamo; A Pessagno; P Tortori-Donati; C Minetti; R Biancheri
Journal:  Neuropediatrics       Date:  2005-08       Impact factor: 1.947

Review 9.  The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Shaw; Andrew Phillips; David N Cooper
Journal:  Hum Genet       Date:  2014-01       Impact factor: 4.132

10.  Feast or famine: role of TRPML in preventing cellular amino acid starvation.

Authors:  Kartik Venkatachalam; Ching-On Wong; Craig Montell
Journal:  Autophagy       Date:  2012-10-09       Impact factor: 16.016

View more
  5 in total

Review 1.  Current concepts in the neuropathogenesis of mucolipidosis type IV.

Authors:  Lauren C Boudewyn; Steven U Walkley
Journal:  J Neurochem       Date:  2018-08-30       Impact factor: 5.372

2.  White matter abnormalities and iron deposition in prenatal mucolipidosis IV- fetal imaging and pathology.

Authors:  Ayelet Zerem; Liat Ben-Sira; Nitzan Vigdorovich; Zvi Leibovitz; Yael Fisher; Raphael Schiffmann; Yulia Grishchuk; Albert L Misko; Naama Orenstein; Dorit Lev; Tally Lerman-Sagie; Debora Kidron
Journal:  Metab Brain Dis       Date:  2021-05-08       Impact factor: 3.584

3.  Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV.

Authors:  Yulia Grishchuk; Karina A Peña; Jessica Coblentz; Victoria E King; Daniel M Humphrey; Shirley L Wang; Kirill I Kiselyov; Susan A Slaugenhaupt
Journal:  Dis Model Mech       Date:  2015-09-17       Impact factor: 5.758

Review 4.  Neuropathophysiology, Genetic Profile, and Clinical Manifestation of Mucolipidosis IV-A Review and Case Series.

Authors:  Aleksandra Jezela-Stanek; Elżbieta Ciara; Karolina M Stepien
Journal:  Int J Mol Sci       Date:  2020-06-26       Impact factor: 5.923

5.  Mucolipidosis Type IV in Omani Families with a Novel MCOLN1 Mutation: Search for Evidence of Founder Effect.

Authors:  Badriya Al-Alawi; Beena Harikrishna; Khalid Al-Thihli; Sana Al Zuhabi; Anuradha Ganesh; Zainab Al Hashami; Zeyana Al Dhamhmani; Razan Zadjali; Nafila B Al Riyami; Fahad Zadjali
Journal:  Genes (Basel)       Date:  2022-01-28       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.